News | February 25, 2010

Hospital Does 98 Percent of MR Exams Contrast-Free

An example of a noncontrast MRA image from Toshiba.

February 26, 2010 - Gadolinium-based contrast agents, the most common contrast agents used for MRA, have been directly linked to nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD) a sometimes fatal skin disease that occurs in patients with renal insufficiency.

In response to concern over gadolinium-based contrast agents, Little Company of Mary, a nonprofit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients.

To accomplish this, the facility installed a magnetic resonance imaging (MRI) system the is capable of using contrast-free MRA techniques. These contrast-free techniques allowed Little Company of Mary to now complete 98 percent of its MRA exams without contrast.

The organization acquired a Vantage Atlas MR unit by Toshiba America Medical Systems Inc. The manufacturer developed the full suite of contrast-free MRA techniques available on the entire Vantage MR product line to combat adverse medical events such as NSF/NFD. These techniques include fresh blood imaging (FBI), contrast-free tmproved angiography (CIA), time-spatial labeling inversion pulse (time-SLIP) and time and space angiography (TSA).

The system also enables the hospital to improve hospital efficiency. For example, by not using contrast the team has reduced the need for rescans that sometimes occurs when a bolus is missed, and they also do not need to run pre-exam lab tests on patients to evaluate renal function.

For more information: www.nocontrast.com

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI)| April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons
Overlay Init